Follow the 리가켐바이오 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 리가켐바이오 has logged 25 insider filings. The latest transaction was disclosed on 1 October 2025 (Purchase). Among the most active insiders: 김용주. Every trade is openly available.
25
Insider Decl.
n/a
Thresholds
n/a
19 ops.
Buy Volume
n/a
2 ops.
Sell Volume
7Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Riga Chem Bio is a company in the health and pharmaceutical sector listed on the XKRX market. It specializes in the development of innovative biopharmaceutical solutions.